Question from Deputy Ken O'Flynn - PQ 16014-26
Deputy O'Flynn asked about the Level 9 Social Work apprenticeship programme. Read the HSE response.
- Published date:
- :
Corporate publications
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Showing 3761 to 3770 of 6986 results
Question from Deputy Gillian Toole - PQ 16104-26
Deputy Toole asked about the contingency plan for the provision of general practitioner services in Ratoath and Dunboyne in Meath. Read the HSE response.
- Published date:
- :
Question from Deputy Charles Ward - PQ 15673-26
Deputy Ward asked about the number of additional staff that needed in each community hospital in Donegal. Read the HSE response.
- Published date:
- :
Question from Deputy Michael Cahill - PQ 15661-26
Deputy Cahill asked about the development of the new 108-bed block on the campus of University Hospital Kerry. Read the HSE response.
- Published date:
- :
Question from Deputy David Cullinane - PQ 16118-26
Deputy Cullinane the staffing levels in cardiac services at University Hospital Waterford (UHW). Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 16039-26
Deputy O'Flynn asked about medical card refusal rates. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 15880-26
Deputy O'Flynn asked about the reimbursement to tirzepatide and semaglutide. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 15879-26
Deputy O'Flynn asked about the budget impact analysis in respect of the proposed reimbursement of tirzepatide and semaglutide for diabetes and weight management
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 15874-26
Deputy O'Flynn asked about the full health technology assessment of tirzepatide type 2 diabetes mellitus and for weight management. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 15815-26
Deputy O'Flynn asked about the full health technology assessment of tirzepatide for type 2 diabetes. Read the HSE response.
- Published date:
- :